Marino, Mariapaola
 Distribuzione geografica
Continente #
NA - Nord America 1.963
EU - Europa 1.467
AS - Asia 637
AF - Africa 17
SA - Sud America 14
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.111
Nazione #
US - Stati Uniti d'America 1.945
SE - Svezia 481
IT - Italia 259
SG - Singapore 239
CN - Cina 234
DE - Germania 208
IE - Irlanda 124
FR - Francia 97
ID - Indonesia 74
UA - Ucraina 67
RU - Federazione Russa 53
GB - Regno Unito 49
IN - India 38
FI - Finlandia 33
BE - Belgio 25
PL - Polonia 17
CA - Canada 16
CI - Costa d'Avorio 11
HK - Hong Kong 11
CH - Svizzera 10
NL - Olanda 10
BR - Brasile 8
ES - Italia 8
IR - Iran 8
AU - Australia 7
TR - Turchia 7
CZ - Repubblica Ceca 6
JP - Giappone 5
KR - Corea 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
BY - Bielorussia 3
KZ - Kazakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
LT - Lituania 2
MX - Messico 2
RO - Romania 2
ZA - Sudafrica 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CY - Cipro 1
IQ - Iraq 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TM - Turkmenistan 1
VN - Vietnam 1
Totale 4.111
Città #
Chandler 532
Ashburn 242
Singapore 193
Dublin 124
San Mateo 89
Jakarta 74
New York 68
Rome 56
Marseille 52
Cattolica 49
Wilmington 49
Princeton 46
Ann Arbor 45
Milan 44
Boston 42
Moscow 42
Jacksonville 41
Bremen 35
Redwood City 33
Beijing 27
Chicago 27
Dearborn 26
Woodbridge 26
Boardman 25
Nanjing 24
Los Angeles 22
Brussels 21
Houston 20
Helsinki 18
Kraków 17
Bologna 16
Falls Church 15
Norwalk 15
Seattle 14
Abidjan 11
Munich 11
Fairfield 10
Washington 10
Edinburgh 9
Lawrence 9
Nanchang 9
Toronto 9
Hebei 8
Hong Kong 8
Chengdu 7
Atlanta 6
Hangzhou 6
Izmir 6
Lancaster 6
London 6
Zurich 6
Brno 5
Changsha 5
Jiaxing 5
Lappeenranta 5
Mountain View 5
Naples 5
Sacramento 5
San Francisco 5
Shenyang 5
São Paulo 5
Auckland 4
Augusta 4
Berlin 4
Bern 4
Falkenstein 4
Melbourne 4
Nürnberg 4
Oslo 4
Ottawa 4
Paris 4
Pune 4
San Jose 4
Tianjin 4
University Park 4
Amsterdam 3
Baltimore 3
Busan 3
Busto Arsizio 3
Dallas 3
Esslingen am Neckar 3
Frankfurt am Main 3
Guangzhou 3
Jinan 3
Kish 3
Kunming 3
Lachine 3
Leawood 3
Minsk 3
Muravera 3
Nuremberg 3
Philadelphia 3
Salt Lake City 3
Santa Clara 3
Shanghai 3
Tokyo 3
Zhengzhou 3
Alatri 2
Almaty 2
Baotou 2
Totale 2.484
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 161
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 151
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 133
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 121
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 118
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 111
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 105
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 102
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 94
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 89
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 83
Immunological role of IgG subclasses 83
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 81
Skeletal muscle cells: from local inflammatory response to active immunity 79
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 79
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 78
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 76
Immunological role of IgG subclasses 75
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 74
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 73
Myasthenia gravis with antibodies to MuSK: an update 72
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 72
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 71
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 68
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 68
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 67
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 66
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 66
The Laboratory Role in anti-TNF Biological Therapy Era 65
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 65
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 64
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 62
Cryoglobulins: putative effectors of adaptive immune response 59
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 58
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 58
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 58
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 56
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 56
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 56
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 54
IL-6, monocyte infiltration and parenchymal cells 54
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 52
Free light chains and autoimmunity 52
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 52
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 50
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 48
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 46
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 46
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 44
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 39
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 39
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 37
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 34
Immune-inflammatory response changes in patients with major depressive disorder 33
The dark side of current analytic methods for Bence Jones Proteinuria 31
Fluidi ed elettroliti. Equilibrio acido-base 30
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 29
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 28
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 28
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 27
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 23
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 23
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 19
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 19
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 19
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 18
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 17
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 16
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 15
Type 2 cytokines and scleroderma interstitial lung disease 15
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 13
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 10
Calprotectin: two sides of the same coin 10
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 9
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 6
Totale 4.258
Categoria #
all - tutte 21.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020144 0 0 0 0 7 11 47 6 5 10 46 12
2020/2021259 22 12 3 16 71 16 16 8 22 6 53 14
2021/2022600 24 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/2025483 75 68 131 66 143 0 0 0 0 0 0 0
Totale 4.258